'Schwesterlein' chosen to represent Switzerland at the Oscars

2020-08-28 02:34:24

Alternative Headline:

(MENAFN- Swissinfo) The film Schwesterlein (My Little Sister) will represent Switzerland at the Oscars in the international feature film category. Whether it is selected for the shortlist will be announced in February.

This content was published on August 28, 2020 - 15:28 August 28, 2020 - 15:28 Keystone-SDA/ts

The film, by Lausanne directors Stéphanie Chuat and Véronique Reymond, tells the story of Lisa, a playwright who has stopped writing and is trying to get her twin brother Sven, a famous but seriously ill actor, back on stage. To do so, she is prepared to do anything, even risk her marriage.

External Content

'Sensitively and without sentimentality, the two directors […] tell the story of an extraordinary sibling relationship, creating a universal drama about family, dying and responsibility as well as the existential force of art,' said the jury in a statement from the Federal Office of Culture on Friday.

Vega Film

Schwesterlein will be released in cinemas on September 3 in German-speaking Switzerland and on September 16 in French-speaking Switzerland.

Standing ovation

The film was produced by Vega Film in Zurich, in collaboration with the Swiss Broadcasting Corporation (swissinfo.ch's parent company) and ARTE GEIE. It premiered in competition at the Berlinale, where it received a standing ovation.

The Academy of Motion Picture Arts and Sciences will publish the shortlist in February and the five Oscar-nominated films in the international feature film category on March 15. The awards ceremony will take place in Los Angeles on April 25.

MENAFN2808202002100000ID1100710838

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.